Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of December 2017. The report addresses a corporate governance event regarding a Special Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report and does not contain financial statements.
Material Changes
There are no material financial changes reported. The primary event is the adjournment of the Special Meeting of Shareholders originally scheduled for December 21, 2017, due to a lack of quorum.
Outlook and Management Commentary
- Meeting Reschedule: The Special Meeting of Shareholders has been reconvened for Thursday, December 28, 2017, at 4:00 p.m. Israel time.
- Location: The meeting will be held at the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
- Reason for Adjournment: The initial meeting failed to achieve the necessary quorum to proceed.
Key Facts for Investor Verification
- Verify the outcome of the reconvened Special Meeting scheduled for December 28, 2017.
- Confirm the specific agenda items intended for shareholder approval at the adjourned meeting.
- Check subsequent filings for any updates on the quorum status or meeting results.